Showing results (531-540 of 607) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|January 23, 2021
Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in JapanKensuke Moriwaki, Saki Uechi, Takaaki Fujiwara, et al.
Pharmacoeconomics - Open|February 21, 2019
Cost of Treatment of Valvular Heart Disease at a Tertiary Hospital in North India: Policy ImplicationsShankar Prinja, Yashpaul Sharma, Jyoti Dixit, et al.
Pharmacoeconomics - Open|March 13, 2019
National Health Insurance Databases in Indonesia, Vietnam and the PhilippinesJunice Yi Siu Ng, Royasia Viki Ramadani, Donni Hendrawan, et al.
Pharmacoeconomics - Open|March 15, 2019
A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South AfricaLetlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, et al.
Pharmacoeconomics - Open|September 20, 2019
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The NetherlandsJudith J Gout-Zwart, Lisa A de Jong, Lisanne Saptenno, et al.
Pharmacoeconomics - Open|November 1, 2018
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled TrialsJoshua K Porter, Gian Luca Di Tanna, Richard B Lipton, et al.
Pharmacoeconomics - Open|November 1, 2018
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in JapanTimothy Bolt, Hisanori Kobayashi, Jörg Mahlich
Pharmacoeconomics - Open|July 13, 2019
A Cost-Effectiveness Analysis Comparing the VivaSight Double-Lumen Tube and a Conventional Double-Lumen Tube in Adult Patients Undergoing Thoracic Surgery Involving One-Lung VentilationSara Larsen, Jimmy Højberg Holm, Tove Nørgaard Sauer, et al.
Pharmacoeconomics - Open|November 16, 2021
Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in BelgiumB Gillain, G Degraeve, T Dreesen, et al.
Pharmacoeconomics - Open|February 7, 2022
Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell LymphomaTimothy A Howell, Louis S Matza, Monika P Jun, et al.
Pageof 61